Vertex Pharmaceuticals (VRTX)

Deferred Revenue

$0.00

Quarterly · Period ending: · USD

VRTX logo

VRTX Deferred Revenue

Latest reported$171.80M
VRTX FY Deferred Revenue ($0.00 → $171.80M)
High-resolution chart · PNG

VRTX deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
171,800,000
206,800,000
170,300,000
159,600,000
171,700,000
191,500,000
62,332,000
24,870,000
237,570,000
79,421,000
16,296,000
17,468,000
21,510,000
27,566,000
45,037,000
74,619,000
74,956,000
37,678,000
25,528,000
33,889,000
31,449,000
47,741,000
7,746,000
11,888,000
39,498,000
28,329,000
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.